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Abstract: Rhamnolipids are known as very efficient biosurfactant molecules. They are 
used in a wide range of industrial applications including food, cosmetics, pharmaceutical 
formulations and bioremediation of pollutants. The present review provides an overview of 
the effect of rhamnolipids in animal and plant defense responses. We describe the current 
knowledge on the stimulation of plant and animal immunity by these molecules, as well as 
on their direct antimicrobial properties. Given their ecological acceptance owing to their 
low toxicity and biodegradability, rhamnolipids have the potential to be useful molecules 
in medicine and to be part of alternative strategies in order to reduce or replace pesticides 
in agriculture. 
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1. Introduction 
Rhamnolipids (RLs) are glycolipid biosurfactants produced by various bacterial species including 
some Pseudomonas sp. and Burkholderia sp. [1]. The structure of RLs is highly diverse and those 
produced  by  Pseudomonas  aeruginosa  have  been  extensively  studied.  These  RLs  are  amphiphilic 
molecules  typically  composed  of  3-hydroxyfatty  acids  linked  through  a  beta-glycosidic  bond  to  
mono-  or  di-rhamnoses  (Figure  1) [2].  RLs  have  several  potential  functions  in  bacteria.  They  are 
involved in the uptake and biodegradation of poorly soluble substrates and are essential for surface 
motility  and  biofilm  development [1].  From  a  biotechnological  point  of  view,  RLs  are  powerful 
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biosurfactants  with  applications  related  to  environmental  concerns,  such  as  bioremediation  of 
hydrocarbon,  organic  pollutants  and  heavy-metal-contaminated  sites.  These  topics  have  been 
extensively  reviewed  including  some  very  recent  articles [3–6].  RLs  have  also  been  used  in  the 
production of fine chemicals, surface coatings, as well as additives for food and cosmetics [7]. Finally, 
a new role for RLs as potential players in the combat of plants and animals against microbes has 
recently  emerged.  For  years  RLs  have  been  extensively  studied  regarding  their  direct  toxicity  to 
microorganisms but recently they have also been reported to be involved in the stimulation of plant 
and animal defense responses. The present review provides an update of the current knowledge on the 
antimicrobial properties of RLs and also highlights the recent discoveries of the involvement of these 
molecules in the stimulation of immunity in plants and animals. The potential use of these molecules 
to fight against pathogenic microorganisms in medical and agricultural field will be discussed.  
Figure  1.  The  major  form  of  rhamnolipid  produced  by  Pseudomonas  aeruginosa  
(Rha-Rha-C10-C10). 
 
2. Rhamnolipids as Antimicrobial Agents 
RLs  have  been  shown  to  display  antibacterial  activities  against  plant  and  human  pathogenic 
bacteria. RLs are known to be active against the Gram-negative bacteria P. aeruginosa, Enterobacter 
aerogenes,  Serratia  marcescens  and  Klebsiella  pneumonia,  as  well  as  against  Gram-positive 
Micrococcus sp., Streptococcus sp., Staphylococcus sp. and Bacillus sp [8–13] (Table 1). RLs have 
direct  impact  on  bacterial  cell  surface  structures.  Al-Tahhan  et  al. [14]  observed  a  loss  of 
lipopolysaccharides (LPS) in P. aeruginosa strains treated with RLs at low concentrations and this 
resulted in increased cell surface hydrophobicity. Recently, Sotirova et al. [15] showed that RLs from 
Pseudomonas sp. PS-17 interact with P. aeruginosa causing a reduction in LPS content and changes in 
the outer membrane proteins  of the bacteria. These changes  had  a direct  impact  on bacterial  cell Int. J. Mol. Sci. 2010, 11                       
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surface morphology. Sotirova et al. [15] concluded that RLs from Pseudomonas sp. PS-17 have a 
potential application in the field of biomedicine against pathogenic bacteria. Several studies described 
antifungal  activity  of  RLs  mainly  against  phytopathogens  including  Botrytis  sp.,  Rhizoctonia  sp., 
Pythium  sp.,  Phytophtora sp.  and  Plasmopara sp. (Table 1) [16–22]. Additionally, RLs  were also 
shown to be active against Mucor miehei and Neurospora crassa [12]. The main mode of action of 
RLs against zoospore-producing plant pathogens is the direct lysis of zoospores via the intercalation of 
RLs within plasma membranes of the zoospore which are not protected by a cell wall [16,21,23]. 
Recent studies also demonstrated an effect of RLs in the reduction of mycelia growth of  Pythium 
myriotylum [18] and Botrytis cinerea [23]. These data suggest that RLs may also have an adverse 
effect  on  cell  structures  that  are  protected  by  a  cell  wall.  Properties  of  RLs  against  the  algae 
Heterosigma akashiwo, viruses, amoeba like Dictyostelium discoideum and mycoplasma have also 
been reported [24–29]. However, RLs’ applications have no significant effects on yeasts [10,12,17,28]. 
In addition to their in vitro antimicrobial activity, RLs have proven to be also efficient in in vivo plant 
systems. Treatments with RLs have been shown to protect pepper plants from Phytophthora blight 
disease  and  also  prevent  the  development  of  Colletotrichum  orbiculare  infection  on  leaves  of 
cucumber plants [17]. Yoo et al. [22] investigated RLs as alternative antifungal agents against typical 
plant  pathogenic  oomycetes,  including  Phytophthora  sp.  and  Pythium  sp.  They  showed  that  RLs 
significantly decrease the incidence of water-borne damping-off disease. Sharma et al. [19] obtained 
similar  results  in  field  trials  on  chili  pepper  and  tomato.  Using  bacterial  mutants,  Perneel  
et  al. [18]  clearly  showed  that  phenazine  and  RLs  interact  in  the  biological  control  of  soil-borne 
diseases caused by Pythium spp. Recent studies also demonstrated that a combination mixture of SRE 
(Syringomycin  E) and RLs is  efficient against pathogenic and opportunistic fungi recovered from 
diseased grape [30,31]. 
Table 1. Antimicrobial properties of rhamnolipids. 
Organisms affected  Observed effects  RL application  RL origin  Ref. 
Fungi         
Alternaria alternata  growth inhibition (MIC)   RL mixture: Rha-Rha-C10-C10, Rha-C10-C10, 
Rha-Rha-C10-C12:1 
P. aeruginosa 
LBI 
[9] 
Alternaria mali   growth inhibition (MIC)  Rha-Rha-C10-C10  P. aeruginosa 
strain B5 
[17] 
Aspergillus niger  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10, 
Rha-Rha-C10-C12:1 
P. aeruginosa 
LBI 
[9] 
Aureobasidium 
pullulans 
growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10, 
Rha-Rha-C10-C12:1 
P. aeruginosa 
LBI 
[9] 
Botrytis cinerea  growth inhibition (MIC)  Rha-Rha-C10-C10  P. aeruginosa 
strain B5 
[17] 
  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C12, Rha-C10-C10, Rha-Rha-C10-C12:1 
P. aeruginosa 
47T2 
[10] 
  inhibition of spore 
germination and 
mycelium growth  
RL mixture: Rha-Rha-C10-C10, Rha-C10-C10  
(Jeneil Biosurfactant Company JBR599) 
P. aeruginosa  [23] 
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Table 1. Cont. 
Organisms affected  Observed effects  RL application  RL origin  Ref. 
Candida albicans  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10, 
Rha-Rha-C10-C12:1 
P. aeruginosa 
LBI 
[9] 
Cercospora kikuchii  growth inhibition (MIC)  Rha-Rha-C10-C10  P. aeruginosa 
strain B5 
[17] 
Chaetonium globosum  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C12, Rha-C10-C10, Rha-Rha-C10-C12:1 
P. aeruginosa 
47T2 
[10] 
  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10, 
Rha-Rha-C10-C12:1 
P. aeruginosa 
LBI 
[9] 
Cladosporium 
cucumerinum 
growth inhibition (MIC)  Rha-Rha-C10-C10  P. aeruginosa 
strain B5 
[17] 
Colletotrichum 
orbiculare 
growth inhibition (MIC)  Rha-Rha-C10-C10  P. aeruginosa 
strain B5 
[17] 
Cylindrocarpon 
destructans 
growth inhibition (MIC)  Rha-Rha-C10-C10  P. aeruginosa 
strain B5 
[17] 
Didymella bryoniae   growth inhibition (MIC)  Rha-Rha-C10-C10  P. aeruginosa 
strain B5 
[17] 
Fusarium solani  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C12, Rha-C10-C10, Rha-Rha-C10-C12:1 
P. aeruginosa 
47T2 
[10] 
Fusarium sp.  growth inhibition (MIC)  Rha-Rha-C10-C10  P. aeruginosa 
strain B5 
[17] 
  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C12, Rha-C10-C10, Rha-Rha-C10-C12:1 
P. aeruginosa 
47T2 
[10] 
Gliocadium virens  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C12, Rha-C10-C10, Rha-Rha-C10-C12:1 
P. aeruginosa 
47T2 
[10] 
  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10, 
Rha-Rha-C10-C12:1 
P. aeruginosa 
LBI 
[9] 
Magnaporthe grisea  growth inhibition (MIC)  Rha-Rha-C10-C10  P. aeruginosa 
strain B5 
[17] 
Mucor miehei  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10  P. aeruginosa 
LBI 
[12] 
Neurospora crassa  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10  P. aeruginosa 
LBI 
[12] 
Penicillium 
funiculosum 
growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C12, Rha-C10-C10, Rha-Rha-C10-C12:1 
P. aeruginosa 
47T2 
[10] 
  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10, 
Rha-Rha-C10-C12:1 
P. aeruginosa 
LBI 
[9] 
Phytophthora sp.  zoospore lysis by RL 
intercalation into 
membrane 
RL mixture: Rha-Rha-C10-C10, Rha-C10-C10  P. aeruginosa  [21] 
  growth inhibition (MIC), 
lytic effect on zoospores 
Rha-Rha-C10-C10  P. aeruginosa 
strain B5 
[17] 
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Table 1. Cont. 
Organisms affected  Observed effects  RL application  RL origin  Ref. 
Phytophthora sp.  zoospore motility 
inhibition, zoospore 
lysis, hyphae growth 
inhibition 
nd  nd  [22] 
  reduction of disease 
incidence and of disease 
severity 
biosurfactant PRO1 (formulation of 25% 
Rls) Plant support (the Netherlands) 
P. aeruginosa  [16] 
  reduction of damping-off 
disease 
RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C10:1, Rha-C10-C10, Rha-Rha-C10-C12:1, 
Rha-C10-C12:1, Rha-C10-C12 , Rha-Rha-C10-
C12, Rha-Rha-C10-C8, Rha-C8-C10, Rha-
Rha-C8-C10, Rha-Rha-C12-C12, Rha-Rha-
C12-C12:1) 
Pseudomonas 
sp. GRP3 
[19] 
Pythium sp.  zoospore lysis by RL 
intercalation into 
membrane 
nd  P. aeruginosa  [21] 
  zoospore motility 
inhibition, zoospore 
lysis, hyphae growth 
inhibition 
nd  nd  [22] 
  reduction of damping-off 
disease 
RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C10:1, Rha-C10-C10, Rha-Rha-C10-C12:1, 
Rha-C10-C12:1, Rha-C10-C12 , Rha-Rha-C10-
C12, Rha-Rha-C10-C8, Rha-C8-C10, Rha-
Rha-C8-C10, Rha-Rha-C12-C12, Rha-Rha-
C12-C12:1) 
Pseudomonas 
sp. GRP3 
[19] 
  mycelial growth 
inhibition, reduction of 
disease symptoms, 
hyphae damages 
RL-deficient mutant   P. aeruginosa 
PA01 
[18] 
Rhizoctonia solani   growth inhibition (MIC)  Rha-Rha-C10-C10  P. aeruginosa 
strain B5 
[17] 
  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C12, Rha-C10-C10, Rha-Rha-C10-C12:1 
P. aeruginosa 
47T2 
[10] 
Bacteria         
Gram-negative         
Enterobacter 
aerogenes  
growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C12, Rha-C10-C10, Rha-Rha-C10-C12:1 
P. aeruginosa 
47T2 
[10] 
  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10, 
Rha-Rha-C10-C12:1 
P. aeruginosa 
LBI 
[9] 
Erwinina carotovora  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C12, Rha-C10-C10, Rha-Rha-C10-C12:1 
P. aeruginosa 
47T2 
[10] 
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Organisms affected  Observed effects  RL application  RL origin  Ref. 
Escherichia coli  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C12, Rha-C10-C10, Rha-Rha-C10-C12:1 
P. aeruginosa 
47T2 
[10] 
  growth inhibition (MIC)  nd  P. fluorescens 
HW-6 
[13] 
Klebsiella pneumoniae  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C12, Rha-C10-C10, Rha-Rha-C10-C12:1 
P. aeruginosa 
47T2 
[10] 
Proteus mirabilis  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10, 
Rha-Rha-C10-C12:1 
P. aeruginosa 
LBI 
[9] 
Pseudomonas 
aeruginosa 
growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10, 
Rha-Rha-C10-C12:1 
P. aeruginosa 
LBI 
[9] 
  increase in released 
proteins  
Biosurfactant PS (rhamnolipid+alginate)  Pseudomonas 
sp. S-17 
[20] 
  reduction of LPS 
contents, increase in cell 
hydrophobicity and  in 
extracellular protein 
release, changes in outer 
membrane proteins 
Biosurfactant PS (rhamnolipid+alginate)  Pseudomonas 
sp. S-17 
[15] 
  growth inhibition, 
increase in cell 
permeability and in 
released proteins  
nd  P. fluorescens 
HW-6 
[13] 
Ralstonia 
solanacearum  
growth inhibition (MIC)  Rha-Rha-C10-C10  P. aeruginosa 
strain B5 
[17] 
Salmonella 
thyphimurium 
growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10, 
Rha-Rha-C10-C12:1 
P. aeruginosa 
LBI 
[9] 
Serratia marcescens  growth inhibition (MIC)  Rha-Rha-C10-C10  P. aeruginosa 
strain B5 
[17] 
  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C12, Rha-C10-C10, Rha-Rha-C10-C12:1 
P. aeruginosa 
47T2 
[10] 
Xanthomonas 
campestris 
growth inhibition (MIC)  Rha-Rha-C10-C10  P. aeruginosa 
strain B5 
[17] 
Gram-positive         
Bacillus cereus  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C12, Rha-C10-C10, Rha-Rha-C10-C12:1 
P. aeruginosa 
47T2 
[10] 
  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10, 
Rha-Rha-C10-C12:1 
P. aeruginosa 
LBI 
[9] 
  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10  P. aeruginosa 
LBI 
[12] 
Bacillus sp.  growth inhibition (MIC)  nd  P. fluorescens 
HW-6 
[13] 
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Organisms affected  Observed effects  RL application  RL origin  Ref. 
Bacillus subtilis  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C12, Rha-C10-C10, Rha-Rha-C10-C12:1 
P. aeruginosa 
47T2 
[10] 
  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10, 
Rha-Rha-C10-C12:1 
P. aeruginosa 
LBI 
[9] 
Micrococcus luteus  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C12, Rha-C10-C10, Rha-Rha-C10-C12:1 
P. aeruginosa 
47T2 
[10] 
  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10, 
Rha-Rha-C10-C12:1 
P. aeruginosa 
LBI 
[9] 
  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10  P. aeruginosa 
LBI 
[12] 
Staphylococcus aureus  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C12, Rha-C10-C10, Rha-Rha-C10-C12:1 
P. aeruginosa 
47T2 
[10] 
  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10  P. aeruginosa 
LBI 
[12] 
Staphylococcus 
epidermidis 
growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-Rha-
C10-C12, Rha-C10-C10, Rha-Rha-C10-C12:1 
P. aeruginosa 
47T2 
[10] 
Streptococcus faecalis  growth inhibition (MIC)  RL mixture: Rha-Rha-C10-C10, Rha-C10-C10, 
Rha-Rha-C10-C12:1 
P. aeruginosa 
LBI 
[9] 
         
Amoeba 
(Dictyostelium 
discoideum) 
growth inhibition, cell 
lysis 
Rhl quorum-sensing mutants  P. aeruginosa 
PA01 
[24] 
Algae (Heterosigma 
akashiwo) 
growth inhibition, cell 
lysis, plasma membrane 
and organelles damages, 
condensation of 
chromatin 
RL mixture: Rha-Rha-C10-C10, Rha-C10-C10  P. aeruginosa  [29] 
Virus         
potato virus X, red 
clover mottle virus 
reduction  of local 
lesions, reduction of 
virus number  
nd  nd  [25] 
herpes simplex virus 
HSV) 
inhibition of cytopathic 
effects 
biosurfactant PS-17 (rhamnolipid+alginate)  Pseudomonas 
sp. S-17 
[27] 
MIC: minimum inhibitory concentrations ; nd : not done or not communicated 
3. Rhamnolipids in Plant and Animal Immunity 
During  the  last  decade,  pattern  recognition  emerged  as  a  fundamental  process  in  the  immune 
response  of  plants  and  animals.  Perception  by  pattern  recognition  receptors  (PRRs)  of  molecular 
signatures that identify whole classes of microbes but are absent from the host allows this nonself 
recognition [32,33].  Once  recognized,  these  molecular  signatures,  conventionally  named  
microbe-associated molecular patterns (MAMPs) [34], trigger complex signaling pathways leading to 
transcriptional activation of defense-related genes and accumulation of antimicrobial metabolites in Int. J. Mol. Sci. 2010, 11                       
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plant  cells [32].  In  mammals,  MAMP  perception  leads  to  the  inflammatory  response  with  the 
production of cytokines including interleukins and the tumor necrosis factor  (TNF). Years ago, 
lipopeptides  were shown to  stimulate human innate immune responses through the PRR Toll-like 
receptor TLR2 perception, by activating the transcriptional activator of multiple host defense genes 
NFkB, the production of interleukin (IL)-12 and the respiratory burst [35–39]. Lipopeptides are also 
involved in the stimulation of innate immunity in plants [40]. It is quite recent that RLs have been 
shown to be involved in triggering plant and animal defense responses and can be described as a new 
class of MAMPs.  
3.1. Rhamnolipids as Stimulators of Human and Animal Immunity 
RLs have been long known as exotoxins produced by the human pathogen P. aeruginosa [41–44] 
and several recent papers have highlighted their role in the stimulation of innate immunity in animal 
cells.  The  heat-stable  Rha-Rha-C14-C14  produced  by  Burkholderia  plantarii  and  some  synthetic 
derivatives have been particularly studied [45–47]. Rha-Rha-C14-C14 is structurally quite similar to the 
RL exotoxin from P. aeruginosa and identical to the RL of Burkholderia pseudomallei, the causative 
agent of melioidosis, an infectious disease of humans and animals leading to skin infection, lung 
nodules and pneumonia [45]. This RL exhibits strong stimulatory activity on human mononuclear cells 
to produce TNF, a pleiotropic inflammatory cytokine. Such a property has not been noted so far for 
RL  exotoxins  but  only  for  the  lipopolysaccharide  (LPS)  bacterial  endotoxins.  Like  LPS,  the  cell 
stimulating  activity  of  this  RL  could  be  inhibited  by  incubation  with  polymyxin  B.  Interestingly, 
immune cell activation by Rha-Rha-C14-C14 does not occur via receptors that are involved in LPS 
(TLR4)  or  lipopeptide  signaling  (TLR2) [45].  Synthetic  RLs  derived  from  B.  plantarii  
Rha-Rha-C14-C14 were also analyzed for their immune cell activation [47]. These synthetic RLs differ 
by variations in the length, stereochemistry, number of lipid chains, number of rhamnoses and the 
occurrence  of  charged  or  neutral  groups.  The  authors  also  compared  these  synthetic  RLs  to  the  
well-characterized LPS MAMP from  Salmonella minnesota. Immunostimulatory properties of RLs 
were  monitored  by  assaying  the  secretion  of  TNF  and  the  induction  of  chemiluminescence  in 
monocytes. Howe et al. [47] found that biological test systems showed large variations, depending on 
particular chemical structures and physicochemical parameters. LPS were, however, more efficient to 
induce  luminescence  and  TNF  production  than  the  RLs  tested.  Furthermore,  they  found  that 
biologically inactive RLs with lamellar aggregate structures antagonize the induced activity in a way 
similar  to  lipid  A-derived  antagonists  of  LPS [47].  An  extended  study  on  structure-activity 
relationships of synthetic RLs derivatives also indicated a specific, recognition-based mode of action, 
with  small  structural  variations  in  the  RLs  resulting  in  strong  effects  on  the  immunostimulatory 
activities [46].  RLs  also  stimulated  the  release  of  interleukin  (IL)-8,  granulocyte-macrophage  
colony-stimulating  factor,  and  IL-6  from  nasal  epithelial  cells  at  non-cytotoxic  levels [48]. 
Interestingly, it was recently demonstrated that RLs could also potentiate the recognition of other 
MAMPs  by  the  human  innate  immune  system.  Several  MAMPs  of  P.  aeruginosa  are  known  to 
activate  the  innate  immune  system  in  epithelial  cells,  particularly  the  production  of  antimicrobial 
peptides  such  as  the  human  beta-defensin-2  (hBD-2)  and  proinflammatory  cytokines  such  as 
interleukin (IL)-8 [49]. In this study, RLs were found to interact with the well-known MAMP flagellin. Int. J. Mol. Sci. 2010, 11                       
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The authors provide evidence that RLs are responsible for the release of flagellin from the flagella. 
Their findings indicate that upon adhesion to surfaces, P. aeruginosa may alter the outer membrane 
composition  in  an  RL-dependent  manner,  thereby  shedding  flagellin  from  the  flagella.  In  turn, 
epithelial cells recognize flagellin leading to synthesis of anti-microbial peptides as well as recruitment 
of inflammatory cells by induction of proinflammatory cytokines [49]. 
3.2. Rhamnolipids as Stimulators of Plant Immunity 
RLs have very recently been characterized as new MAMPs involved in non-specific immunity in 
plants. They have been also shown to induce resistance in plants, which is effective against a broad 
range of pathogens [23]. It is demonstrated that Rha-C10-C10 and Rha-Rha-C10-C10 from P. aeruginosa 
and Rha-Rha-C14-C14 from B. plantarii trigger strong defense responses in grapevine including early 
events of cell signaling like Ca
2+ influx, reactive oxygen species (ROS) production and MAP kinase 
activation.  These  RLs  also  induce  a  large  battery  of  defense  genes  including  some  
pathogenesis-related  protein  genes  and  genes  involved  in  oxylipins  and  phytoalexins  biosynthesis 
pathways [23].  Interestingly,  depending  on  the  concentrations  tested,  RLs  were  able  to  activate  a 
programmed  cell  death  reminiscent  of  animal  apoptosis [23].  It  was  also  demonstrated  that  RLs 
potentiate defense responses induced by other elicitors (i.e., chitosan and a culture filtrate of the fungus 
B.  cinerea).  Another  novel  role  of  RLs  consists  in  protecting  grapevine  against  the  necrotropic 
pathogen B. cinerea. RLs are also active in other plant species. They are able to stimulate defense 
genes in tobacco, wheat and Arabidopsis thaliana (Sanchez, L. unpublished work, 2010). RLs are also 
potent protectors in monocotyledonous plants against biotrophic fungi (Couleaud, G. Arvalis. Private 
communication,  2009).  To  date,  it  is  not  known  whether  the  perception  of  RLs  requires  specific 
receptors in the plant plasma membrane [23]. Interestingly, lipopeptide biosurfactants, which are lipid 
derivatives  with  similar  properties  to  RLs,  have  also  been  described  as  potent  MAMP  elicitors. 
Surfactin, the most studied cyclic lipopeptide from Bacillus subtilis, has been shown to trigger early 
signaling events and late defense responses in tobacco cell suspensions [50]. Some cyclic lipopeptides 
including Massetolide A and fengycin originating, respectively, from Pseudomonas fluorescens SS101 
and  B.  subtilis  S499  were  identified  as  elicitors  inducing  a  systemic  resistance  in  tomato  and 
bean [51,52]. As for RLs, it is yet unclear whether the induction of defense responses by lipopeptides 
requires  specific  receptors  in  the  plant  plasma  membrane [40].  An  alternative  hypothesis  is  that 
lipopeptides could induce defense responses by membrane disturbance [50,53] and this could also be 
the case for RLs. 
4. Potential Use of Rhamnolipids in Agricultural and Biomedical Fields 
Major  breakthroughs  allowing  production,  separation  and  purification  of  RLs  in  industrial 
quantities and laboratory purities have allowed the application of these molecules in different fields 
from cosmetic to industrial and more recently from agriculture to medicine. As previously stated, the 
major advantage of using RL biosurfactants, which have diverse roles in plant and animal systems, is 
that  they  are  natural  and  organic  biodegradable  compounds,  originating  from  a  large  number  of 
bacteria [1]. RLs have also been proposed to be used in food industry applications [12]. RLs have a 
direct  biocide  action  on  bacteria  and  fungi.  They  also  increase  the  susceptibility  of  certain  Int. J. Mol. Sci. 2010, 11                       
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Gram-positive  bacteria  to  specific  antibiotics.  RLs  have  been  demonstrated  to  control  zoosporic 
pathogens through lysis of their zoospores [21]. Clinical trials using RLs for the treatment of psoriasis, 
lichen planus, neurodermatitis and human burn wound healing have confirmed excellent ameliorative 
effects of RLs when compared to conventional therapy using corticosteroids [54,55]. RLs also display 
differential  effects  on  human  keratinocyte  and  fibroblast  cultures [55].  The  advantages  of  these 
biosurfactants are low irritancy and even anti-irritating effects, as well as compatibility with human 
skin [55]. Moreover, RLs have permeabilizing effects on Gram-positive and Gram-negative human 
bacterial strains, reinforcing their potential in biomedicine [20]. An important issue to be taken into 
account is the study of side effects of biosurfactants on plants and animals. Attention should be paid 
while using surfactants on plants as the latter could be affected in many different ways. Parameters like 
negative impact on crop yield or other important agronomical traits should not be neglected and should 
be  studied  in  parallel  to  avoid  any  impact  on  plant  growth  or  metabolism,  while  boosting  plant 
immunity. For instance, it is known that high concentrations of RLs cause necrosis  in plants [23]. 
Dose/response  experiments  in  the  field  are  a  necessity  in  order  to  ensure  use  of  non-toxic 
concentrations of RLs. In addition, in animal systems, RLs are known as virulence factors especially 
for immunocompromised patients and individuals suffering from cystic fibrosis (CF) [1]. At some 
concentrations, RLs also have hemolytic activity [56,57]. Thus, care should be taken in the use of RLs, 
albeit some applications such as fungicide and bactericide are already considered especially for skin 
treatments [54,55].  
5. Conclusion 
RLs are new actors in animal and plant defense and their low toxicity and biodegradability make 
them promising molecules to be used against pathogens. In this respect, there are some clues now 
available  for  the  success  of  RL  applications  in  greenhouses  to  fight  phytopathogens.  A  better 
understanding of RL mode of action, especially their perception and the signaling pathways activated, 
will be very important to potentiate their beneficial effects in plants. RLs have a dual mode of action: 
they are antimicrobial and also stimulate plant defense responses. This dual property is probably very 
important for the efficiency of new biopesticides. In animals, the use of RLs is also at an advanced 
stage. RLs are successfully used as antimicrobial agents, especially for skin disease treatment. Deep 
insight  into  the  physiochemical  effects  of  RLs  and  their  biological  importance  would  reveal  new 
dimensions in the fields of research like agriculture and medicine, precisely in plant defense, disease 
control and pathogenesis. An understanding of bacterial genera producing RLs that are not yet well 
studied would provide light on these fascinating aspects. 
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